NeuExcell Therapeutics logo

NeuExcell Therapeutics Employee Directory

Biotechnology ResearchPennsylvania, United States2-10 Employees

NeuExcell Therapeutics is a biotechnology research company focused on gene therapy approaches for neurodegenerative diseases. The organization aims to regenerate neurons in the brain with the goal of improving outcomes for patients facing serious neurological conditions. Its stated disease areas include stroke, Huntington's disease, ALS, and traumatic brain injury. It is based in King of Prussia, Pennsylvania, and described as a small team in the biotech sector.

The company positions itself within the biotechnology field as pursuing strategies to restore damaged neural tissue through gene therapy. In May 2026, NeuExcell announced that the first-in-human study of NXL-004 for recurrent malignant glioma will be presented at the ASCO 2026 meeting.

Find NeuExcell Therapeutics employees' phone numbers or email addresses

NeuExcell Therapeutics Global Highlights

Location
Employees

North America
9

Minus sign iconPlus sign icon
  • United States Of America
    9

Asia
3

Minus sign iconPlus sign icon
  • China
    3

NeuExcell Therapeutics's Leadership

  • Stylized image of a person
    L. G.
    Chief Business And Strategy Officer
    Phone icon
  • Stylized image of a person
    K. Y.
    Vice President , Head Of Cmc And Tech Ops
    Phone icon
  • Stylized image of a person
    G. C.
    Founder
    Phone icon
  • Stylized image of a person
    M. Z.
    Associate Director,operation
    Phone icon
  • Stylized image of a person
    J. D.
    Financial Director
    Phone icon
  • Stylized image of a person
    T. K. H.
    Director Of Cmc
    Phone icon

NeuExcell Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Business
  • Finance
  • Human Resources
  • Operations
  • Other
  • Biotechnology
  • Accounting
  • Administrative
  • Analytics

Contact profiles from NeuExcell Therapeutics

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    G. C.
    Founder
    Phone icon
    Jun 01, 2026
  • Stylized image of a person
    L. G.
    Chief Business And Strategy Officer
    Phone icon
    Jun 01, 2026
  • Stylized image of a person
    K. Y.
    Vice President , Head Of Cmc And Tech Ops
    Phone icon
    Jun 01, 2026
  • Stylized image of a person
    M. Z.
    Associate Director,operation
    Phone icon
    ChinaShanghai
    Jun 26, 2026
  • Stylized image of a person
    J. D.
    Financial Director
    Phone icon
    Jul 07, 2026
  • Stylized image of a person
    T. K. H.
    Director Of Cmc
    Phone icon
    ChinaJiangsu
    Oct 27, 2025

Frequently Asked Questions

What is NeuExcell Therapeutics known for?

Minus sign iconPlus sign icon
NeuExcell Therapeutics was founded in 2016 operates in the Biotechnology Research industry. Explore NeuExcell Therapeutics's company overview page for more information.

What is NeuExcell Therapeutics's most common email format?

Minus sign iconPlus sign icon
NeuExcell Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more NeuExcell Therapeutics email formats with LeadIQ.

How many employees does NeuExcell Therapeutics have currently?

Minus sign iconPlus sign icon
NeuExcell Therapeutics has approximately 5 employees as of July 2026. These team members are located across 2 continents, including North AmericaAsia.

Who are NeuExcell Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, NeuExcell Therapeutics's key employees include:

  • Chief Business And Strategy Officer: L. G.
  • Vice President , Head Of Cmc And Tech Ops: K. Y.
  • Founder: G. C.
  • Associate Director,operation: M. Z.
  • Financial Director: J. D.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.